| Code | 6220D | ||||||||||
| MA number | 15/0287/20-S | ||||||||||
| Product Form: | plc ifc 5x500 mg (liek.inj.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| Therapeutic Class: | 15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Container: | vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 07.01.2021 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| PIL: |
PIL_Clarithromycin hameln 500 mg plc ifc_06.2022.pdf
|
| SPC: |
SPC_Clarithromycin Hameln 500 mg plc ifc_07.2022.pdf
|
| Safety feature | Yes |
| Data update: | 19.03.2023 |
